α1- Antitrypsin deficiency is associated with –
**Core Concept**
α1-antitrypsin deficiency is a genetic disorder characterized by a deficiency of the enzyme α1-antitrypsin, which protects the lungs from the enzyme neutrophil elastase. This deficiency leads to excessive breakdown of lung tissue, particularly in individuals with a history of smoking.
**Why the Correct Answer is Right**
The correct answer is related to the pathophysiology of α1-antitrypsin deficiency. Individuals with this condition are at an increased risk of developing emphysema and chronic obstructive pulmonary disease (COPD) due to the unregulated activity of neutrophil elastase. The deficiency of α1-antitrypsin leads to the accumulation of abnormal protein in the liver, which can cause liver disease. The enzyme α1-antitrypsin is primarily produced in the liver and secreted into the bloodstream to protect the lungs.
**Why Each Wrong Option is Incorrect**
**Option A:** α1-antitrypsin deficiency is not primarily associated with cardiovascular disease, although individuals with this condition may have an increased risk of cardiovascular disease due to underlying lung disease and other comorbidities.
**Option B:** α1-antitrypsin deficiency is not primarily associated with diabetes mellitus, although individuals with this condition may have an increased risk of developing other comorbidities such as liver disease and respiratory infections.
**Option C:** α1-antitrypsin deficiency is not primarily associated with autoimmune disorders, although individuals with this condition may have an increased risk of developing other comorbidities such as liver disease and respiratory infections.
**Clinical Pearl / High-Yield Fact**
α1-antitrypsin deficiency is an autosomal codominant genetic disorder, and individuals can be classified as ZZ, Z+, or normal based on their genotype and phenotype.
**Correct Answer: D. Emphysema**